BP/AH 01
Alternative Names: BP/AH-01Latest Information Update: 25 Jan 2022
At a glance
- Originator ANGANY Genetics
- Class Food allergy immunotherapies; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Peanut hypersensitivity